Cui Q - Search Results

1

Decitabine in combination with fludarabine and cyclophosphamide as a lymphodepletion regimen followed by CD19/CD22 bispecific targeted CAR T-cell therapy significantly improves survival in relapsed/refractory B-ALL patients.

Ma Y, Dai H, Cui Q, Liu S, Kang L, Lian X, Cui W, Yin J, Liu L, Cai M, Yu L, Wu D, Tang X. Ma Y, et al. Among authors: cui q, cui w. Exp Hematol Oncol. 2023 Apr 10;12(1):36. doi: 10.1186/s40164-023-00397-z. Exp Hematol Oncol. 2023. PMID: 37038230 Free PMC article.

2

[A clinical study of allogeneic hematopoietic stem cell transplantation in 23 patients with early T-cell precursor acute lymphoblastic leukemia].

Zhu YX, Zhu MQ, Dai HP, Liu SN, Yin J, Li Z, Cui QY, Zhu XM, Wu DP, Tang XW. Zhu YX, et al. Among authors: cui qy. Zhonghua Xue Ye Xue Za Zhi. 2019 Dec 14;40(12):1021-1025. doi: 10.3760/cma.j.issn.0253-2727.2019.12.010. Zhonghua Xue Ye Xue Za Zhi. 2019. PMID: 32023734 Free PMC article. Chinese.

3

Early T-Cell Precursor Acute Lymphoblastic Leukemia and T/Myeloid Mixed Phenotype Acute Leukemia Possess Overlapping Characteristics and Both Benefit From CAG-Like Regimens and Allogeneic Hematopoietic Stem Cell Transplantation.

Liu S, Cui Q, Dai H, Song B, Cui W, Xue S, Qiu H, Miao M, Jin Z, Li C, Fu C, Wang Y, Sun A, Chen S, Zhu X, Wu D, Tang X. Liu S, et al. Among authors: cui q, cui w. Transplant Cell Ther. 2021 Jun;27(6):481.e1-481.e7. doi: 10.1016/j.jtct.2021.02.032. Epub 2021 Feb 28. Transplant Cell Ther. 2021. PMID: 33785365 Free article.

4

CD38-directed CAR-T cell therapy: a novel immunotherapy strategy for relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation.

Cui Q, Qian C, Xu N, Kang L, Dai H, Cui W, Song B, Yin J, Li Z, Zhu X, Qu C, Liu T, Shen W, Zhu M, Yu L, Wu D, Tang X. Cui Q, et al. Among authors: cui w. J Hematol Oncol. 2021 May 25;14(1):82. doi: 10.1186/s13045-021-01092-4. J Hematol Oncol. 2021. PMID: 34034795 Free PMC article.

5

[The Effect of Immunized Platelet Transfusion Refractoriness on Allo-HSCT Patients with Malignant Hematological Diseases].

Zuo YL, Zhai JP, Li Y, Jiang M, Cui QY, Tang XW, Zhao YM, Zhang JM. Zuo YL, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2021 Dec;29(6):1923-1928. doi: 10.19746/j.cnki.issn.1009-2137.2021.06.040. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2021. PMID: 34893135 Chinese.

6

Haploidentical CD7 CAR T-cells induced remission in a patient with TP53 mutated relapsed and refractory early T-cell precursor lymphoblastic leukemia/lymphoma.

Dai HP, Cui W, Cui QY, Zhu WJ, Meng HM, Zhu MQ, Zhu XM, Yang L, Wu DP, Tang XW. Dai HP, et al. Biomark Res. 2022 Feb 7;10(1):6. doi: 10.1186/s40364-022-00352-w. Biomark Res. 2022. PMID: 35130959 Free PMC article.

7

Successful application of PD-1 knockdown CLL-1 CAR-T therapy in two AML patients with post-transplant relapse and failure of anti-CD38 CAR-T cell treatment.

Ma YJ, Dai HP, Cui QY, Cui W, Zhu WJ, Qu CJ, Kang LQ, Zhu MQ, Zhu XM, Liu DD, Feng YF, Shen HJ, Liu TH, Qiu HY, Yu L, Wu DP, Tang XW. Ma YJ, et al. Am J Cancer Res. 2022 Feb 15;12(2):615-621. eCollection 2022. Am J Cancer Res. 2022. PMID: 35261791 Free PMC article.

8

Identification of the Predictive Models for the Treatment Response of Refractory/Relapsed B-Cell ALL Patients Receiving CAR-T Therapy.

Gu J, Liu S, Cui W, Dai H, Cui Q, Yin J, Li Z, Kang L, Qiu H, Han Y, Miao M, Chen S, Xue S, Wang Y, Jin Z, Zhu X, Yu L, Wu D, Tang X. Gu J, et al. Among authors: cui q, cui w. Front Immunol. 2022 Mar 17;13:858590. doi: 10.3389/fimmu.2022.858590. eCollection 2022. Front Immunol. 2022. PMID: 35371098 Free PMC article.

9

Case Report: A Case of Acute T Lymphoblastic Leukemia With Mixed Infection of Lethal Invasive Mucormycosis and Multi-Drug Resistant Bacteria.

Cui Q, Dai H, Wu D, He J, Xu Y, Tang X, Xu J. Cui Q, et al. Front Med (Lausanne). 2022 Apr 11;9:854338. doi: 10.3389/fmed.2022.854338. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35479945 Free PMC article.

10

CD7-directed CAR T-cell therapy: a potential immunotherapy strategy for relapsed/refractory acute myeloid leukemia.

Cao X, Dai H, Cui Q, Li Z, Shen W, Pan J, Shen H, Ma Q, Li M, Chen S, Chen J, Zhu X, Meng H, Yang L, Wu D, Tang X. Cao X, et al. Among authors: cui q. Exp Hematol Oncol. 2022 Sep 29;11(1):67. doi: 10.1186/s40164-022-00318-6. Exp Hematol Oncol. 2022. PMID: 36175988 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,861 results

Search Page